Use of postmenopausal hormone replacement therapy by African American women: The importance of physician discussion

Archives of Internal Medicine

Volumn 157, Issue 12, 1997, Pages 1337-1342

  McNagny, Sally E ^a,b   Jacobson, Terry A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; NEGRO; PATIENT COUNSELING; PRIORITY JOURNAL; SOCIOECONOMICS;

EID: 0030947264     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.12.1337     Document Type: Article

References (40)

1. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol. 1995; 85:6-10.
2. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. N Engl J Med. 1985;102:319-324.
3. Hovik P, Sundsbak HP, Gasemyr M, Sandvik L. Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms. Maturitas. 1989;11:75-82.
4. Naessen T, Persson I, Adami HO. Hormone replacement therapy and the risk for first hip fracture: a prospective, population-based cohort study. Ann Intern Med. 1990;113:95-103.
5. Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995; 273:199-208.
6. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117:1016-1037.
7. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991; 20:47-63.
8. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol. 1990;163:1438-1444.
9. Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? data from the Duke established populations for epidemiologic studies of the elderly (EPESE). J Am Geriatr Soc. 1996;44:1-6.
10. Harris RB, Laws A, Reddy VM, King A, Haskell WL. Are women using postmenopausal estrogens? a community survey. Am J Public Health. 1990;80:1266-1268.
11. Hemminki E, Brambilla DJ, McKinlay SM, Posner JG. Use of estrogens among middle-aged Massachusetts women. Ann Pharmacother. 1991;25:418-423.
12. Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement therapy: a survey of women's knowledge and attitudes. Arch Intern Med. 1989;149:133-136.
13. Greendale GA, Carlson KJ, Schiff I. Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists. J Gen Intern Med. 1990;5:464-469.
14. US Dept of Health and Human Services. National Ambulatory Medial Care Survey: 1991 Summary. Hyattsville, Md: US Dept of Health and Human Services; 1994. DHHS publication (PHS) 94-1777.
15. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med. 1992;117:1038-1041.
16. Miles TP, Malik KC. Menopause and African-American women: clinical and research issues. Exp Gerontol. 1994;29:511-518.
17. Remington PL, Smith MY, Williamson DF, Anda RF, Gentry EM, Hogelin GC. Design, characteristics and usefulness of state-based behavioral risk factor surveillance. Public Health Rep. 1988;103:366-375.
18. Williams MV, Parker RM, Baker DW, et al. Inadequate functional health literacy among patients at two public hospitals. JAMA. 1995;274:1677-1682.
19. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol. 1996;143:971-978.
20. Pilote L, Hlatky MA. Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J. 1995;129:1237-1238.
21. Stadel BV, Weiss N. Characteristics of menopausal women: a survey of King and Pierce Counties in Washington, 1973-1974. Am J Epidemiol. 1975;102:209-216.
22. US Dept of Health and Human Services. Anthropometric Reference Data and Prevalence of Overweight: United States, 1976-80. Hyattsville, Md: US Dept of Health and Human Services; 1987. Public Health Service publication 87-1688.
23. Nabulsi AA, Folsom AR, White A, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328:1069-1075.
24. Kellie SE, Brody JA. Sex-specific and race-specific hip fracture rates. Am J Public Health. 1990;80:326-328.
25. Barrett-Connor E. Prevalence, initiation, and continuation of hormone replacement therapy. J Women's Health. 1995;4:143-148.
26. Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy: a survey of older women's attitudes. Arch Intern Med. 1996;156:1293-1297.
27. Bush TL, Barrett-Connor E, Cowan LD, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the lipid research clinics program follow-up study. Circulation. 1987;75:1102-1109.
28. Criqui MH, Suarez L, Barrett-Connor E, McPhillips J, Wingard DL, Garland C. Postmenopausal estrogen use and mortality. Am J Epidemiol. 1988;128:606-614.
29. Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991;151:75-78.
30. Pettiti DB, Perlman JA, Sidney S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek study. Obstet Gynecol. 1987;70: 289-293.
31. Wilson PWF, Garrison RJ, Castelli WP. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. N Engl J Med. 1985; 313:1038-1043.
32. Eaker ED, Castelli WP. Coronary heart disease and its risk factors among women in the Framingham study. In: Eaker E, Packard B, Wenger NK, Clarkson TB, Tyroler HA, eds. Coronary Heart Disease in Women. New York, NY: Haymarket Doyma; 1987:122-132.
33. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R. Factors influencing the age at natural menopause. J Chronic Dis. 1987;40:955-1002.
34. American College of Obstetricians and Gynecologists. Hormone Replacement Therapy. Washington, DC: American College of Obstetricians and Gynecologists; 1992;166:1-8.
35. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa, Ontario: Canada Communication Group; 1994.
36. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams & Wilkins; 1996.
37. Tunis SR, Hayward RSA, Wilson MC, et al. Internists attitudes about clinical practice guidelines. Ann Intern Med. 1994;120:956-963.
38. Woolf S. A new reality in medicine, III: impact on patient care. Arch Intern Med. 1993;153:2646-2655.
39. Davis DD, Thompson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705.
40. Gemson DH, Ashford AR, Dickey LO, et al. Putting prevention into practice: impact of a multifaceted physician education program on preventive services in the inner city. Arch Intern Med. 1995;155:2210-2216.